Related Experiment Video
Updated: Jun 15, 2026
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Familial malignant melanoma - overview
1International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. debniak@wp.pl.
Abstract:
Approximately 3-15% of all malignant melanomas (MM) are familial cases. MM is a highly heterogeneous tumour type from a genetic perspective. Pedigrees with disease confined to a single generation of siblings or MM occurring among second- or third-degree relatives suggest multifactorial polygenic inheritance. However, not infrequently, within large families aggregations of MM are consistent with autosomal dominant inheritance, suggesting a hereditary syndrome caused by germline alterations of a single gene. Several different genes are involved in the development of MM. However, even when taken together they are responsible for less than 20% of all MM cases. It is thus necessary to perform association studies focused on genetic markers that could be used in identifying patients with a high risk of MM. Evaluation of aggregations of MM and other malignancies, like breast cancer, could be essential in identifying relatives of MM probands being at high risk of developing malignancies other than MM. The ultimate goal is to apply in these cases prevention recommendations and surveillance protocols to reduce the disease risk.
Insights
Familial malignant melanoma (MM) cases suggest genetic links. Identifying genetic markers and associated cancer risks is crucial for early detection and prevention strategies in high-risk families.
Area of Science:
- Genetics
- Oncology
- Dermatology
Background:
- Malignant melanoma (MM) exhibits significant genetic heterogeneity, with 3-15% of cases being familial.
- Familial MM can indicate multifactorial polygenic inheritance or autosomal dominant inheritance due to single-gene germline alterations.
Purpose of the Study:
- To identify genetic markers for predicting MM risk.
- To evaluate co-occurrence of MM with other malignancies, such as breast cancer, in families.
- To inform prevention and surveillance protocols for high-risk individuals and families.
Main Methods:
- Review of existing literature on familial melanoma genetics.
- Analysis of pedigree data suggesting inheritance patterns.
- Association studies focusing on genetic markers.
Main Results:
- Current known genes account for less than 20% of all MM cases, highlighting the need for further research.
- Aggregation of MM and other cancers (e.g., breast cancer) within families suggests shared genetic predispositions.
Conclusions:
- Identifying novel genetic markers is essential for stratifying MM risk.
- Understanding familial cancer aggregation aids in identifying at-risk relatives for other malignancies.
- Implementing targeted prevention and surveillance can reduce disease burden in high-risk populations.
Related Concept Videos
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
02:21Cancers Originate from Somatic Mutations in a Single Cell
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:23Abnormal Proliferation